Company Data
Fulcrum Therapeutics Inc.
Ticker
FULC
Current Price
$3.1409 0.03%
Market Cap
$209.2M
Price Target
Refer to Report
Volume
1.4M
52wk Range
$2.83 - $15.7399
Overview
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability.